
Mark Faries, MD, discusses how CAR T-cell and TCR cell therapies compare with TIL approaches in melanoma.

Your AI-Trained Oncology Knowledge Connection!


Mark Faries, MD, is a surgical oncologist at Cedars‑Sinai and The Angeles Clinic and Research Institute. He also serves as associate director of Surgical Oncology Experimental Therapeutics in the Cedars Sinai Department of Surgery, and is head of surgical oncology at Cedars-Sinai Medical Center.